RHONDA MARSH: Open Payments
NPI 1629048715 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 66 payments from 11 companies in 2025. Trend: 2023 $1,341 · 2024 $1,033 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $240 |
| Amneal Pharmaceuticals LLC | 13 | $237 |
| Collegium Pharmaceutical, Inc. | 8 | $176 |
| Novo Nordisk Inc | 9 | $139 |
| Astellas Pharma US Inc | 6 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Exact Sciences Corporation | 4 | $66 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
Products named: UNITHROID, Jornay PM, VRAYLAR, Veozah, UBRELVY, REXULTI, Ozempic, Wegovy.
Industry payments across IN — which companies pay providers there.
